🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 88% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

8.3 Gram(s) Serving Size
30 Servings
Other Combinations Product Type
88% Evidence Coverage

Supplement Facts — Evidence Check

35 mg (219% DV)
✅ 2.5× RDA — within safe limits 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 35mg UL 35mg
2 mg (118% DV)
✅ 1.5× RDA — within safe limits 📚 113 studies (Tier A: 3, B: 35)
RDA 1.3mg This product: 2mg UL 100mg
800 mcg (200% DV)
✅ 2.0× RDA — within safe limits 📚 225 studies (Tier A: 10, B: 105)
RDA 0.4mg This product: 0.8mg UL 1.0mg
25 mcg (1042% DV)
📊 10.4× RDA — above typical dose 📚 138 studies (Tier A: 1, B: 44)
RDA 0.0024mg This product: 0.025mg
200 mg (36% DV)
✅ Within RDA (0.4× RDA of 550 mg) 📚 36 studies (Tier A: 1, B: 7)
RDA 550mg This product: 200mg UL 3500mg
📊 Market median: 5.0mg (298 products) 📚 701 studies (Tier A: 5, B: 123)
This product: 2000mg
1600 mg
📊 Market median: 1500.0mg (104 products) 📚 21 studies (Tier A: 0, B: 2)
This product: 1600mg
ENGN Mind-to-Muscle Matrix
2562 mg

Other Ingredients

Citric Acid Natural & Artificial Flavors Malic Acid Sucralose Silica Acesulfame Potassium FD&C Red #40

Label Claims — Verification

All Other
Structure/Function
All Other (97% of products) Structure/Function (86% of products) Nutrient (36% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating)

Product Information

📋 Directions for Use

Suggested use: As a dietary supplement, take 1 scoop with 8 oz (236mL) of cold water 15-30 minutes before training. To avoid sleeplessness, do not take within 4 hours of sleep.

⚠️ Warnings & Precautions

Warning: Not for use by those with pre-existing medical conditions; those taking any medications; those under the age of 18; those who are caffeine, niacin or Beta-Alanine sensitive or women who are contemplating pregnancy, pregnant or nursing. Consult your physician prior to using this product if you are taking any prescription or over-the-counter medications or supplements. Do not use this product if you are at risk or are being treated for any medical condition including, but not limited to: high or low blood pressure; cardiac arrhythmia; stroke; heart, liver, kidney or thyroid disease; seizure disorder; psychiatric disease; diabetes; difficulty urinating due to prostate enlargement or if you are taking a MAO inhibitor.

Warning: Not for use by those with pre-existing medical conditions; those taking any medications; those under the age of 18; those who are caffeine, niacin or Beta-Alanine sensitive or women who are contemplating pregnancy, pregnant or nursing. Keep out of reach of children.

Discontinue use and consult your healthcare professional if you experience any adverse reaction to this product. Do not exceed recommended serving size or suggested use for any reason. Discontinue use 2 weeks prior to surgery.

Product contains 300mg of total caffeine per serving.

🧪 Formulation Notes

This product is made in the USA, has been distributed and manufactured by a (GMP) registered facility and contains ingredients of domestic and international origin. ENGN Pre-Workout, when combined with regular training, is engineered to support: Training harder Amplified pumps Explosive power Intense energy Strength Focus

Intense energy Explosive power Amplified pumps Pre-workout engine Maximum focus

Pink Lemonade Naturally and artificially flavored

Additional Information

Instagram Facebook Twitter @EVLSports #EVL

Made in the USA

Product Details

UPC / SKU 8 18901 02045 0
DSLD Entry Date 2025-03-25
Product Type Other Combinations
Form Powder
DSLD ID 326389
Data Updated 2026-04-11

Research Evidence

241 Research Sources
55 Avg Quality Score
113 Meta Analysis
75 Systematic Review
32 Rct
11 Clinical Trial
3 Other
3 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016
View all evidence for Niacin →

Compare Similar Products

View all Niacin products →